
Analysis from Komodo Health and Medscape Education shows cognitive screening up 10% and biomarker testing up 23%, yet significant disparities persist in detection for women and treatment access for Black...

The new ‘Brain Health Matters’ campaign urges the public to prioritise brain health

The companies will focus on developing therapeutics across neuroscience, immunology and oncology

The deal gives the company access to a range of central nervous system disorder drugs

The companies will advance therapeutics for undisclosed targets in Novartis’ core areas

The deal includes a candidate in phase 1 development for Alzheimer's disease

The companies will advance small molecule therapeutics against a new class of targets for cancer

The companies will focus on targets in oncology, neuroscience and inflammation

The agreement gives Novartis access to three preclinical neuroscience programmes
Lucy Jung, CEO & Founder of Charco Neurotech, shares how meeting members of the Parkinson's community catalyzed the founding of Charco and how #innovative medical devices and software can improve...
Lucy Jung, CEO & Founder of Charco Neurotech, shares how meeting members of the Parkinson's community catalyzed the founding of Charco and how #innovative medical devices and software can improve...

Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022.